Social Media Use in Sickle Cell Patients

Survey, Family Life Clinical Trial

Official title:

Social Media Use in Sickle Cell Patients

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT05182216
• Other study ID #: 300007766
• Status: Withdrawn
• Start date: January 1, 2023
• Est. completion date: December 31, 2023

Study information

• Verified date: January 2023
• Source: University of Alabama at Birmingham
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Surveys of patients to identify primary social media sources for health news.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 31, 2023
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• sickle cell disease diagnosis

Exclusion Criteria:

• negative sickle cell disease diagnosis

Related Conditions & MeSH terms

• Survey, Family Life

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Alabama at Birmingham

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Social Media Use in Sickle Cell Patients	Surveys. The survey will have a variety of social media options and ask participants to select the medium used to receive information on health, news, and entertainment.	six months